Renovaro and Biosymetrics Announce Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 27, 2025
Renovaro Biosciences Inc., a TechBio leader focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, announced a definitive agreement to merge with BioSymetrics,